Revolutionizing Cancer Care: The Future of Longevity Medicine w/ Ben Blue Ora Biomedical

In this episode of Next Round Ready, host Chris welcomes back Ben Blue, founder of Ora Biomedical, to discuss the latest advancements in his company focused on cancer care therapies. Ben shares his unique background, growing up in a four-generation household in Alaska, which sparked his fascination with aging and health. Ouro Biomedical aims to develop therapies that enhance the resilience of healthy cells during cancer treatments like radiation and chemotherapy, addressing a significant unmet need in patient care. Ben emphasizes the importance of narrowing down their focus from broad ideas to actionable solutions that can make a real impact in the near term.Chapters00:00 Introduction to Ouro Biomedical01:07 The Journey of Ben Blue and Ouro Biomedical02:38 Focusing on Cancer Care Therapies06:38 Traction and Funding Success10:07 Navigating the Path to Market11:57 Fundraising Strategy and Future Goals15:12 Vision for the Future of Longevity MedicineGet connected with active investors on Compass!Follow the show on YouTubeGet your Fundability Session: https://tr.ee/ItVpU4Zia1LinkedIn: https://www.linkedin.com/company/next-round-readyThe Brand: https://nextroundready.com